Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of BI 1060469 in Healthy Asian Males
NCT02183545Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jul 2014
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in asthma comparing BI 1060469 with Placebo (2 arms). Primary endpoint: Number of subjects with drug-related adverse events up to 14 days. Started Jul 2014; status: completed.
02
Drugs
BI 1060469
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02183545.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02183545.